Wiley Bros. Aintree Capital, LLC Jazz Pharmaceuticals PLC Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 3,672 shares of JAZZ stock, worth $521,497. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,672Holding current value
$521,497% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
542Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$873 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$857 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$359 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$315 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$289 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.9B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...